Ponni V Perumalswami
Overview
Explore the profile of Ponni V Perumalswami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
1061
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen V, Tedesco N, Hu J, Jasty V, Perumalswami P
Am J Med
. 2025 Jan;
PMID: 39842541
Introduction: Social determinants of health are key factors driving disease progression. In type 2 diabetes there is limited literature on how distal or intermediate factors (eg, those at the neighborhood...
2.
3.
Barnard Giustini A, Patel A, Cheung R, Nobbe A, Perumalswami P, Johnson R, et al.
Liver Transpl
. 2024 Jun;
30(11):E48-E49.
PMID: 38920367
No abstract available.
4.
Integrated Hepatitis C-Opioid Use Disorder Care Through Facilitated Telemedicine: A Randomized Trial
Talal A, Markatou M, Liu A, Perumalswami P, Dinani A, Tobin J, et al.
JAMA
. 2024 Apr;
331(16):1369-1378.
PMID: 38568601
Importance: Facilitated telemedicine may promote hepatitis C virus elimination by mitigating geographic and temporal barriers. Objective: To compare sustained virologic responses for hepatitis C virus among persons with opioid use...
5.
Perumalswami P, Adams M, Frost M, Holleman R, Kim H, Zhang L, et al.
Alcohol Clin Exp Res (Hoboken)
. 2024 Mar;
48(5):944-954.
PMID: 38529689
Background: The use of telehealth treatment of alcohol use disorder (AUD) has increased since the start of the COVID-19 pandemic. However, it is unclear which patients are using telehealth and...
6.
Winder G, Fernandez A, Perumalswami P, Mellinger J, Clifton E
Liver Transpl
. 2023 Nov;
30(4):431-442.
PMID: 38009890
Psychosocial and "nonmedical" phenomena are commonly encountered in liver transplantation (LT) evaluations. They are simultaneously crucial decision-making factors and some of the most difficult and controversial clinical matters clinicians confront....
7.
Perumalswami P, Winder G, Fernandez A, Mellinger J
Am J Gastroenterol
. 2023 Sep;
119(4):591-595.
PMID: 37725695
No abstract available.
8.
Talal A, George S, Talal L, Dharia A, Ventuneac A, Baciewicz G, et al.
Res Involv Engagem
. 2023 Aug;
9(1):63.
PMID: 37533127
Background: People who use drugs (PWUD) have difficulty participating in clinical research. We evaluated approaches to engage PWUD in clinical research, using facilitated telemedicine for hepatitis C virus (HCV) care...
9.
Winder G, Clifton E, Denysenko L, DiChiara A, Hathaway D, Perumalswami P, et al.
Liver Transpl
. 2023 Jul;
30(2):213-222.
PMID: 37486958
Liver transplantation (LT) teams must be adept at detecting, evaluating, and treating patients' alcohol use, given its prominence among psychological and behavioral phenomena which cause and contribute to liver diseases....
10.
Hershman M, Torbjornsen K, Pang D, Wyatt B, Dieterich D, Perumalswami P, et al.
Obes Sci Pract
. 2023 Jun;
9(3):218-225.
PMID: 37287520
Objective: The Diabetes Prevention Program (DPP) is the gold standard lifestyle modification program that reduces incident type 2 diabetes mellitus. Patients with prediabetes and patients with non-alcoholic fatty liver disease...